Ernexa Therapeutics posts new investor presentation; details not disclosed in filing

Ernexa Therapeutics Inc.

Company made a December 2025 investor presentation available via 8-K and its website.
No financial or operational data from the presentation is included in the filing.
Investors will need to access the company website to view the presentation content.

item 7.01 item 9.01

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-027167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.